Novavax, Inc. (NVAX) vs Xencor, Inc. (XNCR)
A side-by-side comparison of Novavax, Inc. and Xencor, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NVAX
Novavax, Inc.
$10.96HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
XNCR
Xencor, Inc.
$24.38HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
Total return — NVAX vs XNCR
growth of $100 · dividends reinvested · last 10yNVAX -68.6% (-10.9%/yr)XNCR +10.1% (+1.0%/yr)XNCR compounded faster over this window
NVAX XNCR
NVAX vs XNCR: by the numbers
- •XNCR is the larger company ($1.81B vs $1.80B market cap).
- •Both run net losses; NVAX's is the smaller (-59.87% vs -155.59% net margin).
- •NVAX grew revenue faster over the past five years (118.86% vs 0.47% CAGR).
Metrics side by side
Valuation
| Metric | NVAX | XNCR |
|---|---|---|
| P/S ratio | 4.36 | 17.22 |
| P/B ratio | N/A | 3.59 |
Profitability
| Metric | NVAX | XNCR |
|---|---|---|
| Gross margin | 93.67% | 91.63% |
| Operating margin | 50.14% | -141.35% |
| Net margin | -59.87% | -155.59% |
| ROE | N/A | -32.46% |
| ROIC | -36.37% | -33.60% |
Growth (annualized)
| Metric | NVAX | XNCR |
|---|---|---|
| Revenue CAGR (5Y) | 118.86% | 0.47% |
| Total return CAGR (5Y) | -40.61% | -6.46% |
Frequently asked
- Which has grown faster, NVAX or XNCR?
- Over the past five years, NVAX grew revenue faster — NVAX at a 118.86% CAGR versus XNCR at 0.47%.
- How have NVAX and XNCR total returns compared?
- Over the past 10 years, NVAX delivered -10.98% and XNCR delivered 0.77% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Novavax ROEXencor ROENovavax operating marginXencor operating marginNovavax revenue growthXencor revenue growthNovavax free cash flowXencor free cash flow
Novavax & Xencor appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.